Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on Capital EmployedReturn on Invested CapitalTimes Interest Earned

Lifecore Biomedical, Inc. \De\ (LFCR) Equity Ratio (2016 - 2025)

Lifecore Biomedical, Inc. \De\ has reported Equity Ratio over the past 15 years, most recently at 0.01 for Q2 2025.

  • Quarterly results put Equity Ratio at 0.01 for Q2 2025, down 87.47% from a year ago — trailing twelve months through May 2025 was 0.01 (down 87.47% YoY), and the annual figure for FY2025 was 0.01, down 87.47%.
  • Equity Ratio for Q2 2025 was 0.01 at Lifecore Biomedical, Inc. \De\, down from 0.01 in the prior quarter.
  • Over the last five years, Equity Ratio for LFCR hit a ceiling of 0.44 in Q1 2022 and a floor of 0.06 in Q3 2023.
  • Median Equity Ratio over the past 5 years was 0.11 (2023), compared with a mean of 0.18.
  • Biggest five-year swings in Equity Ratio: tumbled 118.88% in 2023 and later soared 946.45% in 2024.
  • Lifecore Biomedical, Inc. \De\'s Equity Ratio stood at 0.37 in 2021, then crashed by 30.12% to 0.26 in 2022, then tumbled by 97.76% to 0.01 in 2023, then soared by 946.45% to 0.06 in 2024, then tumbled by 90.77% to 0.01 in 2025.
  • The last three reported values for Equity Ratio were 0.01 (Q2 2025), 0.01 (Q1 2025), and 0.06 (Q4 2024) per Business Quant data.